Dovato

Dovato is a combination medication containing Lamivudine and Dolutegravir Sodium, used for HIV treatment. This oral medication is manufactured by Viiv Healthcare B.V. and is suitable for adults living with HIV-1.

Dovato is primarily used in the treatment of HIV-1 infection. It combines two active ingredients, Lamivudine and Dolutegravir Sodium, to help manage the virus. This medication is designed for adults who are starting HIV treatment or switching from other regimens. Dovato is not a cure for HIV but helps control the virus, reducing the amount of HIV in the body.

Common effects of Dovato may include headache, diarrhea, and nausea. Some individuals might experience fatigue or difficulty sleeping. These effects vary among users and are not experienced by everyone. If any effects are severe or persistent, it is important to consult a healthcare provider.

Dovato should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions. This medication is not suitable for everyone, and precautions should be taken if you have liver or kidney problems. Always inform your healthcare provider about any other medications you are taking.

Dovato may interact with certain medications, including some antacids, supplements, and other HIV drugs. It is important to avoid taking Dovato with products containing dolutegravir or lamivudine. Always consult a healthcare provider before starting any new medication while taking Dovato.